- £2.46bn
- £1.72bn
- ZAR134.33bn
- 28
- 93
- 72
- 73
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Other Revenue | |||||
Total Revenue | 174,778 | 143,979 | 244,184 | 77,466 | 134,330 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 160,982 | 147,251 | 232,142 | 71,026 | 120,474 |
Operating Profit | 13,796 | -3,272 | 12,042 | 6,440 | 13,856 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 13,796 | -3,272 | 13,427 | 6,558 | 13,966 |
Provision for Income Taxes | |||||
Net Income After Taxes | 9,551 | -5,348 | 7,463 | 5,651 | 7,633 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 9,386 | -5,097 | 6,662 | 5,231 | 7,065 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 9,386 | -5,097 | 6,662 | 5,231 | 7,065 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.57 | 1.04 | 1.68 | 1.47 | 1.86 |
Dividends per Share |